Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic

BACKGROUND: India has the world’s highest tuberculosis burden, and Mumbai is particularly affected by multidrug resistant tuberculosis (MDR-TB). WHO recommends short, intensive treatment (“Short Course”) for previously untreated pulmonary MDR-TB patients but does not require universal drug susceptib...

Descripción completa

Detalles Bibliográficos
Autores principales: Udwadia, Zarir F., Tornheim, Jeffrey A., Ganatra, Shashank, DeLuca, Andrea, Rodrigues, Camilla S., Gupta, Amita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350313/
https://www.ncbi.nlm.nih.gov/pubmed/30691407
http://dx.doi.org/10.1186/s12879-019-3726-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350313/
https://www.ncbi.nlm.nih.gov/pubmed/30691407
http://dx.doi.org/10.1186/s12879-019-3726-8

Ejemplares similares